Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to -$84.3 million.

  • Utah Medical Products' Enterprise Value rose 473.14% to -$84.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.3 million, marking a year-over-year increase of 473.14%. This contributed to the annual value of -$83.0 million for FY2024, which is 1065.17% up from last year.
  • Per Utah Medical Products' latest filing, its Enterprise Value stood at -$84.3 million for Q3 2025, which was up 473.14% from -$82.2 million recorded in Q2 2025.
  • Utah Medical Products' Enterprise Value's 5-year high stood at -$56.0 million during Q1 2021, with a 5-year trough of -$93.8 million in Q1 2024.
  • Moreover, its 5-year median value for Enterprise Value was -$82.2 million (2025), whereas its average is -$77.3 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 4145.1% in 2021, then skyrocketed by 1117.5% in 2025.
  • Quarter analysis of 5 years shows Utah Medical Products' Enterprise Value stood at -$61.0 million in 2021, then decreased by 23.09% to -$75.1 million in 2022, then decreased by 23.74% to -$92.9 million in 2023, then grew by 10.65% to -$83.0 million in 2024, then dropped by 1.56% to -$84.3 million in 2025.
  • Its last three reported values are -$84.3 million in Q3 2025, -$82.2 million for Q2 2025, and -$83.3 million during Q1 2025.